Adverum Biotechnologies, Inc. (ADVM) SEC filings
ADVM SEC filings moved a median of +2.52% by the close. ADVM SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ADVM overview →
60 measured ADVM SEC filing events.
Where these ADVM SEC filings landedvs 52 measured ADVM SEC filing reactions
| Middle 50% of ADVM SEC filing reactions | -2.24% to +7.56% |
|---|---|
| Median reaction (to close) | +2.52% |
| Measured reactions | 52 |
Point-in-time · zero look-ahead
Half of the 52 ADVM SEC filing events with a measured close landed between -2.24% and +7.56%; 60% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G Adverum Biotechnologies, | SEC filing · Form 15-12G | — | — | |
| Form EFFECT Adverum Biotechnologies, | SEC filing · Form EFFECT | — | — | |
| Form 8-K Adverum Biotechnologies, For: Dec 09 | SEC filing · Form 8-K | — | — | |
| Form POS AM Adverum Biotechnologies, | SEC filing · Form POS | — | — | |
| Form S-8 POS Adverum Biotechnologies, | SEC filing · Form S-8 | — | — | |
| Form 8-K Adverum Biotechnologies, For: Dec 04 | SEC filing · Form 8-K | +0.72% | +2.65% | |
| Form 8-K Adverum Biotechnologies, For: Nov 19 | SEC filing · Form 8-K | +0.72% | -0.72% | |
| Form 10-Q Adverum Biotechnologies, For: Sep 30 | SEC filing · Form 10-Q | +0.12% | — | |
| Form 8-K Adverum Biotechnologies, For: Oct 24 | SEC filing · Form 8-K | +0.91% | -7.50% | |
| Form 8-K Adverum Biotechnologies, For: Sep 22 | SEC filing · Form 8-K | +13.33% | -14.57% | |
| Form 10-Q Adverum Biotechnologies, For: Jun 30 | SEC filing · Form 10-Q | +1.77% | — | |
| Form 8-K Adverum Biotechnologies, For: Aug 12 | SEC filing · Form 8-K | +1.77% | — | |
| Form S-8 Adverum Biotechnologies, | SEC filing · Form S-8 | -1.32% | -2.19% | |
| Form 8-K Adverum Biotechnologies, For: Jun 17 | SEC filing · Form 8-K | +3.43% | -1.72% | |
| Form DEFA14A Adverum Biotechnologies, | SEC filing · Form DEFA14A | +0.45% | +1.79% | |
| Form 10-Q Adverum Biotechnologies, For: Mar 31 | SEC filing · Form 10-Q | -2.00% | +2.50% | |
| Form 8-K Adverum Biotechnologies, For: May 14 | SEC filing · Form 8-K | -2.00% | +2.50% | |
| Form ARS Adverum Biotechnologies, For: Dec 31 | SEC filing · Form ARS | +2.10% | +12.94% | |
| Form DEF 14A Adverum Biotechnologies, For: Jun 17 | SEC filing · Form DEF | +2.10% | +12.94% | |
| Form DEFA14A Adverum Biotechnologies, | SEC filing · Form DEFA14A | +2.10% | +12.94% | |
| Form PRE 14A Adverum Biotechnologies, For: Jun 17 | SEC filing · Form PRE | +0.86% | -6.51% | |
| Form 10-K Adverum Biotechnologies, For: Dec 31 | SEC filing · Form 10-K | +1.77% | -4.72% | |
| Form 8-K Adverum Biotechnologies, For: Apr 15 | SEC filing · Form 8-K | +1.77% | -4.72% | |
| Form 8-K Adverum Biotechnologies, For: Mar 28 | SEC filing · Form 8-K | +1.01% | -10.09% | |
| Form NT 10-K Adverum Biotechnologies, For: Dec 31 | SEC filing · Form NT | +1.01% | -10.09% | |
| Form S-8 Adverum Biotechnologies, | SEC filing · Form S-8 | -3.78% | +8.03% | |
| Form S-8 Adverum Biotechnologies, | SEC filing · Form S-8 | +2.60% | +2.82% | |
| Form 8-K Adverum Biotechnologies, For: Nov 18 | SEC filing · Form 8-K | -1.46% | -8.76% | |
| Form 10-Q Adverum Biotechnologies, For: Sep 30 | SEC filing · Form 10-Q | -0.92% | +2.52% | |
| Form 8-K Adverum Biotechnologies, For: Nov 04 | SEC filing · Form 8-K | -0.92% | +2.52% | |
| Form 10-Q Adverum Biotechnologies, For: Jun 30 | SEC filing · Form 10-Q | +4.88% | +3.21% | |
| Form 8-K Adverum Biotechnologies, For: Aug 12 | SEC filing · Form 8-K | +4.88% | +3.21% | |
| Form 8-K Adverum Biotechnologies, For: Jul 17 | SEC filing · Form 8-K | +5.30% | +11.66% | |
| Form S-8 Adverum Biotechnologies, | SEC filing · Form S-8 | +0.00% | -0.14% | |
| Form 8-K Adverum Biotechnologies, For: Jun 17 | SEC filing · Form 8-K | +1.15% | -0.15% | |
| Form 8-K Adverum Biotechnologies, For: Jun 06 | SEC filing · Form 8-K | +3.71% | +8.10% | |
| Form DEFA14A Adverum Biotechnologies, | SEC filing · Form DEFA14A | +3.71% | +8.10% | |
| Form DEFA14A Adverum Biotechnologies, | SEC filing · Form DEFA14A | -0.27% | +3.51% | |
| Form 10-Q Adverum Biotechnologies, For: Mar 31 | SEC filing · Form 10-Q | +4.23% | -1.59% | |
| Form 8-K Adverum Biotechnologies, For: May 09 | SEC filing · Form 8-K | +4.23% | -1.59% | |
| Form ARS Adverum Biotechnologies, For: Dec 31 | SEC filing · Form ARS | +1.68% | +3.27% | |
| Form DEF 14A Adverum Biotechnologies, For: Jun 17 | SEC filing · Form DEF | +1.68% | +3.27% | |
| Form DEFA14A Adverum Biotechnologies, | SEC filing · Form DEFA14A | +1.68% | +3.27% | |
| Form EFFECT Adverum Biotechnologies, | SEC filing · Form EFFECT | -0.77% | -2.25% | |
| Form EFFECT Adverum Biotechnologies, | SEC filing · Form EFFECT | -2.05% | +3.53% | |
| Form S-3 Adverum Biotechnologies, | SEC filing · Form S-3 | +1.29% | +12.23% | |
| Form 8-K Adverum Biotechnologies, For: Mar 20 | SEC filing · Form 8-K | +1.98% | -5.99% | |
| Form 10-K Adverum Biotechnologies, For: Dec 31 | SEC filing · Form 10-K | +0.33% | +10.00% | |
| Form 8-K Adverum Biotechnologies, For: Mar 18 | SEC filing · Form 8-K | +0.33% | +10.00% | |
| Form S-8 Adverum Biotechnologies, | SEC filing · Form S-8 | +0.33% | +10.00% | |
| Form S-3 Adverum Biotechnologies, | SEC filing · Form S-3 | +2.99% | -3.09% | |
| Form D Adverum Biotechnologies, | SEC filing · Form D | +2.58% | +1.55% | |
| Form 8-K Adverum Biotechnologies, For: Feb 08 | SEC filing · Form 8-K | -26.44% | -33.22% | |
| Form 8-K Adverum Biotechnologies, For: Feb 06 | SEC filing · Form 8-K | +1.24% | +15.64% | |
| Form 8-K Adverum Biotechnologies, For: Feb 05 | SEC filing · Form 8-K | -8.50% | +25.63% | |
| Form 8-K Adverum Biotechnologies, For: Dec 06 | SEC filing · Form 8-K | -4.46% | -2.23% | |
| Form 8-K/A Adverum Biotechnologies, For: Nov 03 | SEC filing · Form 8-K | +2.23% | +6.43% | |
| Form 10-Q Adverum Biotechnologies, For: Sep 30 | SEC filing · Form 10-Q | +1.24% | +7.41% | |
| Form 8-K Adverum Biotechnologies, For: Nov 09 | SEC filing · Form 8-K | +1.24% | +7.41% | |
| Form 8-K Adverum Biotechnologies, For: Nov 03 | SEC filing · Form 8-K | +12.46% | -2.54% |
Keep exploring
More ADVM: earnings → · analyst actions → · ADVM overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| MENLO THERAPEUTICS INC COMMON (MNLO) | 308 | 0.00% | 49% |
| Syros Pharmaceuticals, Inc. (SYRS) | 307 | +0.51% | 55% |
| Establishment Labs Holdings Inc. - Common Shares (ESTA) | 306 | +0.13% | 52% |
| Syndax Pharmaceuticals, Inc. (SNDX) | 306 | +0.04% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.